safety evaluation of empagliflozin for patients with type 2 diabetes and chronic kidney disease
Published 11 months ago • 1.6K plays • Length 11:52
Download video MP4
Download video MP3
Similar videos
-
3:21
empa ckd - 3 min trial summary
-
1:06:58
e-seminar #1 new pharmacological therapies to slow the progression of diabetic kidney disease
-
2:12
how are ckd, cvd, and diabetes related? | the kidney disease, heart disease, and diabetes connection
-
2:16
what is diabetes? | the kidney disease, heart disease, and diabetes connection | nkf
-
2:58
diabetic kidney disease, animation
-
6:09
how diabetes destroys the human body
-
4:29
acute v chronic kidney disease: can they be reversed?
-
1:05:41
stage 3 ckd: diabetes and kidney disease | american kidney fund
-
8:40
chronic kidney disease - causes, symptoms, diagnosis, treatment, pathology
-
1:52
empa-kidney results: empagliflozin reduces kidney disease progression and cardiovascular deaths
-
5:15
kidney disease in diabetes: implications for therapy pt 1/4 (featuring dr. defronzo)
-
6:14
metformin and kidney disease: safety, history and efficacy explained
-
3:53
diabetes care in renal disease: clinical considerations
-
9:06
sglt2 inhibitors in chronic kidney disease
-
3:06
empagliflozin: a game changer for chronic kidney disease
-
2:19
empagliflozin | medicine information
-
5:02
diabetes is the number 1 cause of chronic kidney disease [diabetic kidney disease] - ckd series #2
-
3:41
jennifer green, easd 2022: finerenone & empagliflozin in patients with ckd and t2d: confidence study
-
2:40
a diabetes drug might also save patients with acute kidney injury
-
58:16
evidence based reduction of cardiovascular & renal outcomes in diabetes
-
9:59
recovery trial - empagliflozin
-
11:46
empagliflozin and progression of kidney disease in type 2 diabetes
Clip.africa.com - Privacy-policy